The Institute for Molecular Medicine Exclusively Licenses MultiTEP, a Universal Vaccine Platform Technology, to New Biotechnology Company Nuravax

HUNTINGTON BEACH, Calif.: HUNTINGTON BEACH, Calif., Sept. 29, 2021 /PRNewswire/ -- The Institute for Molecular Medicine (IMM), a non-profit scientific research organization established in 1996 with the goal of understanding, preventing and curing chronic diseases, including neurodegenerative disorders, today announced the licensing of its universal vaccine platform technology, MultiTEP, to...

Click to view original post